Botanix ca­pac­ity lift

Pharmacy Daily - - Front page -

ASX-LISTED med­i­cal der­ma­tol­ogy com­pany Botanix Phar­ma­ceu­ti­cals has an­nounced the ap­point­ment of two highly qual­i­fied global phar­ma­ceu­ti­cal in­dus­try ex­ec­u­tives to ex­pand the com­pany’s clin­i­cal de­vel­op­ment ca­pa­bil­i­ties.

Dr Stephane Levy has taken up the role of chief med­i­cal of­fi­cer and Jil­lian Cha­pas-Reed is se­nior di­rec­tor of Clin­i­cal Op­er­a­tions.

Their ap­point­ments bring sig­nif­i­cant clin­i­cal ex­per­tise in acne, der­mati­tis and pso­ri­a­sis and ex­ten­sive late stage clin­i­cal de­vel­op­ment ex­pe­ri­ence to Botanix, help­ing ac­celler­ate the BTX 1503 acne and BTX 1204 atopic der­mati­tis Phase 2 clin­i­cal tri­als.

Both Phase 2 clin­i­cal tri­als are fully funded, the com­pany said in its ASX an­nounce­ment (PD 28 Jun).

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.